Clinical advances in EGFR-TKI combination therapy for EGFR-mutated NSCLC: a narrative review

Zhang, QR; Wang, R; Xu, L

Xu, L (通讯作者),Shanghai Jiao Tong Univ, Sch Med, Dept Pharmacol & Chem Biol, 227 Chongqing South Rd,Ruijin Second Rd St, Shanghai 200025, Peoples R China.

TRANSLATIONAL CANCER RESEARCH, 2023; 12 (12): 3764

Abstract

Background and Objective: Mutations located in epidermal growth factor receptor (EGFR) tyrosine kinase domains have been described as the 'Achilles he......

Full Text Link